Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Mechanical Instability of Methane Hydrate–Mineral Interface Systems حسب Pinqiang Cao (4520677)

Mechanical Instability of Methane Hydrate–Mineral Interface Systems حسب Pinqiang Cao (4520677)

Mechanical Instability of Methane Hydrate–Mineral Interface Systems حسب Pinqiang Cao (4520677)

Excessive LF4A kinase activity shortens cilia and decreases IFT. حسب Yu-Yang Jiang (7036916)

Purity and stability of the recombinant C-terminal domain of PPX (<i>Ec</i>PPXc). حسب Benedetta Manca (15810991)

Characteristics of the study participants admitted at Asella Referral & Teaching Hospital, January, 2020 G.C. حسب Firaol Lemessa Kitila (11402219)

الموضوعات:

TUNNEL assay representing apoptosis in <i>C</i>. <i>auris</i>. حسب Hammad Alam (530008)

الموضوعات:

Seasonal variation of fish distribution in vertical structure expressed as the relationship between <i>Sv</i> (volume backscattering strength) and <i>D</i> (depth of fish school),... حسب Yanhui Zhu (6697751)

The HMR C-terminus is required for HMR localization in proximity to centromeres and HP1a-bound chromatin (related to Fig 4). حسب Andrea Lukacs (3752956)

Inactivation of <i>ICL1</i> bypasses the effects of <i>MLS1</i> inactivation. حسب Cynthia Alsayyah (18452506)

الموضوعات:

Neutrophils from HIV-infected individuals with high CD4 T-cell count have increased IL-10 activity and decreased glycolysis. حسب Garett Dunsmore (11021169)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

الموضوعات:

The rate the bias decreases with sample duration is higher for cells with higher activity levels. حسب Liron Sheintuch (12078310)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Activation is greater for youth in the before prize condition (<i>n</i> = 226) vs. after prize condition (<i>n</i> = 220) during large win > small win trials in the MTwiNS sample (... حسب Melissa K. Peckins (12042132)

Overview of the six original ACTIV-3/TICO trials. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Baseline patient characteristics across neutralizing monoclonal antibody trials. حسب Elizabeth S. Munroe (21568166)

الموضوعات:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. حسب Elizabeth S. Munroe (21568166)

الموضوعات: